Rating
Buy
Price target
$502
Previous
Implied upside
+17%

Cantor Fitzgerald analyst Thomas Blakey reiterated an Overweight rating and $502.00 price target on Microsoft (NASDAQ: MSFT).

“Microsoft hosted Build 2026 this week, which was scaled back this year with an apparent increasing focus on developers and with announcements centered on the company’s evolution from Copilot as a collection of AI assistants to a fullstack enterprise agent platform spanning proprietary models, contextual grounding, agent runtimes, governance, security, developer tools, scientific discovery, quantum and new AI-native device form factors.

We view this much deeper iteration and coalescence around the AI/intelligence layer impressive and come away incrementally more positive on Microsoft’s positioning across the AI stack, as the company is connecting its core solutions into a more cohesive platform for deploying, securing and monetizing enterprise agents.

As such, we continue to view the narrative as shifts in 2HC26 and into 2027 from AI will ultimately disrupt the software industry, and certain software platforms (i.e., Microsoft) will benefit from AI.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.